These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Moldrich RX; Chapman AG; De Sarro G; Meldrum BS Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743 [TBL] [Abstract][Full Text] [Related]
4. Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. Tatarczyńska E; Pałucha A; Szewczyk B; Chojnacka-Wójcik E; Wierońska J; Pilc A Pol J Pharmacol; 2002; 54(6):707-10. PubMed ID: 12866729 [TBL] [Abstract][Full Text] [Related]
5. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies. Domin H; Przykaza Ł; Jantas D; Kozniewska E; Boguszewski PM; Śmiałowska M Neuropharmacology; 2016 Mar; 102():276-94. PubMed ID: 26647070 [TBL] [Abstract][Full Text] [Related]
7. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Pałucha A; Tatarczyńska E; Brański P; Szewczyk B; Wierońska JM; Kłak K; Chojnacka-Wójcik E; Nowak G; Pilc A Neuropharmacology; 2004 Feb; 46(2):151-9. PubMed ID: 14680755 [TBL] [Abstract][Full Text] [Related]
8. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord. Howson PA; Jane DE Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233 [TBL] [Abstract][Full Text] [Related]
9. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene. De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606 [TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774 [TBL] [Abstract][Full Text] [Related]
11. Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats. Kłak K; Pałucha A; Brański P; Sowa M; Pilc A Amino Acids; 2007 Feb; 32(2):169-72. PubMed ID: 16868652 [TBL] [Abstract][Full Text] [Related]
12. Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice. Pałucha-Poniewiera A; Novák K; Pilc A Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1454-7. PubMed ID: 19660510 [TBL] [Abstract][Full Text] [Related]
14. Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents. Pałucha-Poniewiera A; Kłodzińska A; Stachowicz K; Tokarski K; Hess G; Schann S; Frauli M; Neuville P; Pilc A Neuropharmacology; 2008 Sep; 55(4):517-24. PubMed ID: 18619473 [TBL] [Abstract][Full Text] [Related]
15. Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine. Folbergrová J; Haugvicová R; Mares P Exp Neurol; 2003 Mar; 180(1):46-54. PubMed ID: 12668148 [TBL] [Abstract][Full Text] [Related]
16. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice. De Sarro G; Renne S; Nava F; De Sarro A J Pharm Pharmacol; 1994 Dec; 46(12):1017-22. PubMed ID: 7714713 [TBL] [Abstract][Full Text] [Related]
17. The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice. Moldrich RX; Talebi A; Beart PM; Chapman AG; Meldrum BS Neurosci Lett; 2001 Feb; 299(1-2):125-9. PubMed ID: 11166954 [TBL] [Abstract][Full Text] [Related]
18. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182 [TBL] [Abstract][Full Text] [Related]
19. Activation of presynaptic group III metabotropic receptors enhances glutamate release in rat entorhinal cortex. Evans DI; Jones RS; Woodhall G J Neurophysiol; 2000 May; 83(5):2519-25. PubMed ID: 10805653 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes. Acher FC; Tellier FJ; Azerad R; Brabet IN; Fagni L; Pin JP J Med Chem; 1997 Sep; 40(19):3119-29. PubMed ID: 9301676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]